CAVALETTI, GUIDO ANGELO
 Distribuzione geografica
Continente #
NA - Nord America 48.811
EU - Europa 23.383
AS - Asia 12.156
SA - Sud America 391
OC - Oceania 108
AF - Africa 80
Continente sconosciuto - Info sul continente non disponibili 60
Totale 84.989
Nazione #
US - Stati Uniti d'America 47.897
IT - Italia 4.569
CN - Cina 4.251
SG - Singapore 3.986
DE - Germania 3.791
SE - Svezia 3.263
IE - Irlanda 3.164
RU - Federazione Russa 2.519
UA - Ucraina 2.413
HK - Hong Kong 1.813
GB - Regno Unito 1.108
CA - Canada 868
FI - Finlandia 656
AT - Austria 508
VN - Vietnam 490
FR - Francia 394
ID - Indonesia 366
IN - India 347
BR - Brasile 321
DK - Danimarca 265
NL - Olanda 214
TR - Turchia 200
JP - Giappone 197
KR - Corea 184
BE - Belgio 137
AU - Australia 87
IR - Iran 68
PL - Polonia 66
ES - Italia 56
EU - Europa 53
TW - Taiwan 51
MY - Malesia 38
CZ - Repubblica Ceca 35
CH - Svizzera 34
PT - Portogallo 32
RO - Romania 30
PK - Pakistan 28
MX - Messico 27
EG - Egitto 25
NZ - Nuova Zelanda 21
GR - Grecia 20
HR - Croazia 19
UZ - Uzbekistan 18
PH - Filippine 16
EC - Ecuador 15
PE - Perù 15
AR - Argentina 14
BG - Bulgaria 14
IL - Israele 13
SA - Arabia Saudita 13
ZA - Sudafrica 13
NO - Norvegia 12
RS - Serbia 12
TH - Thailandia 12
AE - Emirati Arabi Uniti 11
CL - Cile 10
IQ - Iraq 10
SC - Seychelles 10
BD - Bangladesh 9
HU - Ungheria 7
LU - Lussemburgo 7
MA - Marocco 7
CO - Colombia 6
GT - Guatemala 6
LT - Lituania 6
MD - Moldavia 6
LB - Libano 5
SI - Slovenia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AL - Albania 4
BY - Bielorussia 4
DZ - Algeria 4
JO - Giordania 4
LV - Lettonia 4
MU - Mauritius 4
PA - Panama 4
TN - Tunisia 4
VE - Venezuela 4
A1 - Anonimo 3
BO - Bolivia 3
EE - Estonia 3
JM - Giamaica 3
KG - Kirghizistan 3
KW - Kuwait 3
SK - Slovacchia (Repubblica Slovacca) 3
AO - Angola 2
AZ - Azerbaigian 2
BH - Bahrain 2
CR - Costa Rica 2
ET - Etiopia 2
GE - Georgia 2
KE - Kenya 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MN - Mongolia 2
MT - Malta 2
NG - Nigeria 2
OM - Oman 2
PY - Paraguay 2
TT - Trinidad e Tobago 2
Totale 84.974
Città #
Ann Arbor 9.449
Woodbridge 4.641
Fairfield 3.560
Houston 3.434
Singapore 3.185
Dublin 3.073
Chandler 2.845
Jacksonville 2.527
Frankfurt am Main 2.295
Wilmington 2.277
Ashburn 2.178
Hong Kong 1.765
Dearborn 1.763
Milan 1.447
Seattle 1.385
Princeton 1.244
New York 1.236
Santa Clara 1.187
Cambridge 1.183
Nanjing 719
Boardman 578
Shanghai 504
Lawrence 459
Vienna 451
Altamura 450
Hangzhou 450
Beijing 419
Lachine 413
Jakarta 355
Guangzhou 257
Dong Ket 256
Council Bluffs 226
Nanchang 219
Andover 204
Helsinki 204
San Diego 202
Toronto 201
Shenyang 195
Rome 158
Hebei 154
Falls Church 134
Tianjin 123
Chicago 120
Ottawa 119
Changsha 116
Fremont 116
Jiaxing 116
Grafing 112
Kazan 112
Brussels 111
Jinan 110
Los Angeles 108
Mountain View 100
London 91
Norwalk 88
Huizen 85
Pune 85
Detroit 79
Kunming 75
Carate Brianza 74
Nuremberg 74
Ningbo 71
Zhengzhou 67
Nürnberg 58
Melzo 57
Hefei 55
Dallas 53
Edmonton 50
Washington 48
Florence 47
San Mateo 47
Munich 44
Redmond 43
Tokyo 43
Leawood 38
Daejeon 37
Lissone 34
Turin 34
Phoenix 32
Sydney 32
Taizhou 32
Sacramento 31
São Paulo 31
Bergamo 30
Bologna 30
Paris 30
Philadelphia 30
Kiev 29
Naples 29
Auburn Hills 28
Bari 27
Saint Petersburg 27
University Park 27
Brno 26
Romola 26
Lappeenranta 25
Catania 24
Kocaeli 24
Mainz 24
Fuzhou 23
Totale 61.339
Nome #
La citofluorimetria a flusso nella caratterizzazione immunofenotipica dei linfociti in corso di Encefalite Autoimmune Sperimentale. 503
Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice 416
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 395
Comparing the different response of PNS and CNS injured neurons to mesenchymal stem cell treatment 355
Nelarabine-Induced Neurotoxicity: Reversible Damage not only on Peripheral Nerves 352
Design and Synthesis of Chitosan—Gelatin Hybrid Hydrogels for 3D Printable in vitro Models 337
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 327
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 312
Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)4]PF6 and [Au(P)4]PF6 (P = thp or PTA) Anticancer Complexes 312
Antitumoral Effect of Hibiscus sabdariffa on Human Squamous Cell Carcinoma and Multiple Myeloma Cells 305
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 305
Malattie del Sistema Nervoso 303
Age-related changes in the function and structure of the peripheral sensory pathway in mice 302
Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings 301
Tubulin polymerization and mitochondria transport involvement in Bortezomib peripheral neurotoxicity. 297
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 297
Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics 296
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 293
Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells 288
Quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis 287
ETNK1 MUTATIONS INCREASE MITOCHONDRIAL ACTIVITY AND PROMOTE DNA DAMAGE THROUGH ROS PRODUCTION 281
An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection 277
The Italian multiple sclerosis register 273
Protective Effect of Human Mesenchymal Stem Cells on the Survival of Pancreatic Islets 272
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine 268
ETNK1 mutations promote ROS production and DNA damage through increased mitochondrial activity 265
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) 255
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 255
Anti-multiple myeloma potential of secondary metabolites from hibiscus sabdariffa 255
Enhanced brain targeting of engineered solid lipid nanoparticles 250
Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as neuroprotective agents 250
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine 250
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 247
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 241
Functional Magnetic Resonance Imaging of Rats with Experimental Autoimmune Encephalomyelitis Reveals Brain Cortex Remodeling 239
Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve 237
Glutamatergic Homeostasis Impairment in Multiple Sclerosis Patients 236
A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer 234
Neuropathic pain is reduced in acid sphingomyelinase deficient mice. 233
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity 233
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 226
Malattie del Sistema Nervoso 224
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS) 221
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 220
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings 220
Reliability of clinical outcome measures in Charcot-Marie-Tooth disease 219
Are sigma receptor modulators a weapon against multiple sclerosis disease? 219
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 219
Genetic determinants of chronic oxaliplatin-induced peripheral neurotoxicity: A genome-wide study replication and meta-analysis 218
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 217
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 217
Neurotoxicity of platinum compounds: comparison of the effects of cisplatin and oxaliplatin on the human neuroblastoma cell line SH-SY5Y 216
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 212
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 210
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect 210
Role of MAPKs in platinum-induced neuronal apoptosis 209
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 208
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 206
Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells 205
Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study 205
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 203
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 201
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 199
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 198
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline 198
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 198
Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis 197
Low-dose cisplatin protects human neuroblastoma SH-SY5Y cells from paclitaxel-induced apoptosis 195
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 194
An unusual transthyretin gene missense mutation (TTR Phe33Val) linked to familial amyloidotic polyneuropathy 192
Effect of trans-resveratrol on signal transduction pathways involved in paclitaxel-induced apoptosis in human neuroblastoma SH-SY5Y cells 192
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 191
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 191
Human platelets express the synaptic markers VGLUT1 and 2 and release glutamate following aggregation 190
Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancer 190
NCI Clinical Trials Planning Meeting for prevention and treatment of chemotherapy-induced peripheral neuropathy 190
Pain in chemotherapy-induced peripheral neurotoxicity 189
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 188
Effect of recombinant human nerve growth factor on cisplatin neurotoxicity in rats 188
Neuropathic pain and chemotherapy-induced peripheral neurotoxicity: the issue 188
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 187
Histological features of nerve fibers and endoneural vessels in a case of Wegener's granulomatosis. 186
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 186
Hemorrhagic infarction: risk factors, clinical and tomographic features, and outcome. A case-control study 185
The Italian neuromuscular registry: A coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usage 184
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 183
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 182
Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNoms study 182
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 182
Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools 182
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 181
Validation of the Italian version of the Neuropathic Pain Symptom Inventory in peripheral nervous system diseases 181
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 181
Oxidative stress and inflammation induced by acute and subacute ultrafine exposure: contrinbution to alzheimer's disease 181
Effects of Manidipine and Delapril in Hypertensive Patients With Type 2 Diabetes Mellitus: The Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND) Randomized Clinical Trial 180
Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients 180
Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents 179
Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth 178
Atypical CIDP: Diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database 178
Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease 177
Totale 23.442
Categoria #
all - tutte 323.573
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 323.573


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.388 0 0 0 0 0 0 0 994 1.315 900 898 281
2020/202111.730 705 487 1.422 1.222 840 908 1.351 1.075 1.006 1.072 606 1.036
2021/20227.268 464 759 732 672 492 676 355 400 350 499 561 1.308
2022/202312.644 1.552 3.530 1.184 1.077 893 1.970 170 657 896 141 314 260
2023/202410.575 335 389 450 424 1.434 2.369 1.959 439 786 247 246 1.497
2024/202512.496 1.585 2.872 1.748 1.200 2.163 931 1.391 606 0 0 0 0
Totale 89.003